✨ 100% Authentic — guaranteed🚚 Free delivery on orders over ৳2,000🇧🇩 Fast delivery across Bangladesh💳 Cash on delivery available🎁 New arrivals every week
Product image 1
Product image 2
Product image 3
Product image 4
Product image 5
Product image 6
Product image 7
INKEYINKEY

The INKEY List Tranexamic Acid Serum (30 ml)

No reviews yet
100% Authentic guaranteed✦ Earn 140 points with this product
From BDT 2,800.00
Quantity
1
  • Free shipping on orders over BDT 1,990
  • Estimated delivery by 2–3 days
Need help? Chat with us on WhatsApp
The INKEY List Tranexamic Acid Serum (30 ml)
BDT 2,800.00

The INKEY List Tranexamic Acid Serum (30 ml) is a targeted dark spot corrector formulated to visibly fade hyperpigmentation, acne marks, melasma, and uneven tone. Featuring 2% Tranexamic Acid, this powerful nighttime treatment reduces discoloration caused by UV exposure, hormones, and breakouts — revealing a brighter, more even complexion. This Tranexamic Acid Serum works by blocking excess melanin production to prevent new dark spots from forming. Additionally, it contains Acai Berry Extract and Vitamin C derivatives, which boost antioxidant protection and improve skin clarity. As a result, your skin looks more uniform, fresh, and radiant with consistent use. Moreover, the lightweight, non-sticky texture absorbs quickly and layers well with your regular skincare routine. Since the formula is gentle and non-irritating, it suits all skin types, including sensitive or acne-prone skin. Even better, the serum works overnight so you wake up to visible improvements every morning. The INKEY List ensures clean, minimalist ingredients without added fragrance, parabens, or harsh acids — making it a smart choice for people dealing with stubborn pigmentation in humid climates like Bangladesh. With daily use, the Tranexamic Acid Serum helps reduce tanning, fade post-acne marks, lighten dark patches, and restore confidence in your natural skin tone.

Have questions about the product?

AI answers coming soon — replies are placeholders for now.